Emtricitabine and Tenofovir Disoproxil Fumarate and Incruse Ellipta
Determining the interaction of Emtricitabine and Tenofovir Disoproxil Fumarate and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and tenofovir
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine and Tenofovir Disoproxil Fumarate-Indacaterol
- Emtricitabine and Tenofovir Disoproxil Fumarate-Indacaterol and Glycopyrrolate
- Emtricitabine and Tenofovir Disoproxil Fumarate-Indacaterol and glycopyrrolate Inhalation
- Emtricitabine and Tenofovir Disoproxil Fumarate-Indacaterol inhalation
- Emtricitabine and Tenofovir Disoproxil Fumarate-Indacaterol Maleate
- Emtricitabine and Tenofovir Disoproxil Fumarate-Indapamide
- Incruse Ellipta-Emtricitabine and Tenofovir Tablets
- Incruse Ellipta-Emtricitabine Capsules
- Incruse Ellipta-Emtricitabine Solution
- Incruse Ellipta-Emtricitabine, lopinavir, ritonavir, and tenofovir
- Incruse Ellipta-Emtricitabine, nelfinavir, and tenofovir
- Incruse Ellipta-Emtricitabine, rilpivirine, and tenofovir